[144] RESMED INC SEC Filing
Form 144 filing: An affiliate, Brett Sandercock, filed notice to sell 3,000 shares of the issuer’s Common stock through Fidelity Brokerage Services on the NYSE, reflecting an aggregate market value of $742,620 and an approximate sale date of 11/03/2025.
The shares derive from two sources: 2,000 shares tied to an option granted on 11/14/2018 (cash payment dated 11/03/2025) and 1,000 shares from restricted stock vesting on 11/11/2022 (compensation). Shares outstanding were 145,966,294.
Recent activity shows prior sales by the same filer of 3,000 shares on 09/02/2025 for $812,310 and 3,000 shares on 10/01/2025 for $823,080. This notice outlines a proposed disposition method and quantity; actual sales depend on market conditions and execution.
- None.
- None.